Enliven Therapeutics
ELVN
#5556
Rank
S$1.37 B
Marketcap
$28.18
Share price
-0.86%
Change (1 day)
26.89%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$23 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are S$23 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$34.28 M-84.03%
2022-12-31S$0.21 B1.64%
2021-12-31S$0.21 B5.51%
2020-12-31S$0.20 B